Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Personalized Therapeutic Neuromodulation for Anhedonic Depression

NCT: NCT05144789 · COMPLETED

NCT IDNCT05144789
StatusCOMPLETED
Start Date2022-05-31
Completion2025-12-31
SponsorStanford University (OTHER)
First posted
Last updated

Brief Summary

This study will investigate the anti-anhedonic efficacy of a novel neurostimulation strategy termed accelerated intermittent theta burst stimulation (aiTBS) in participants with treatment resistant depression (TRD).

Frequently Asked Questions

What is Personalized Therapeutic Neuromodulation for Anhedonic Depression?

Personalized Therapeutic Neuromodulation for Anhedonic Depression is a clinical trial registered under NCT05144789. Current status: COMPLETED.

What is the status of NCT05144789?

The current status of NCT05144789 (Personalized Therapeutic Neuromodulation for Anhedonic Depression) is: COMPLETED.

When did Personalized Therapeutic Neuromodulation for Anhedonic Depression start?

Personalized Therapeutic Neuromodulation for Anhedonic Depression started on 2022-05-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑